Sorrento Therapeutics, Inc.
Anti-OX40 binding proteins

Abstract:

The present disclosure provides anti-OX40 antibodies, and antigen-binding portions thereof. In certain embodiments, the antibodies or fragments thereof, are used for the treatment of cancer.